For D gene usage, healthy controls tended to use TRBD1 more (p = 0.062, Figure 3C), while TRBD2 was significantly more used in APS-1 patients (p = 0.041, Figure 3C). This evidence concerns the gene TRBD1 and autoimmune polyendocrine syndrome type 1.